老年综合评估的成本效果:经济学评价的系统综述
该系统综述纳入17项针对≥65岁衰弱或不良结局风险人群的老年综合评估(CGA)经济学评价,覆盖社区和医院等7种场景。13项成本效用分析中增量质量调整生命年(QALY)范围为-0.06至0.54,增量成本为€-12 744至€29 785,CGA具有成本效果的概率在0%至98.9%之间;结论认为CGA的成本效果仍不确定,异质性可能与CGA资源强度、衰弱严重程度、居住状态和场景有关。
要点
- CGA的成本效果在不同研究和场景间差异大,13项成本效用分析中5项具成本效果、7项不具、1项概率50%。
- 增量QALY范围为-0.06至0.54,增量成本范围为€-12 744至€29 785,成本效果概率0%至98.9%。
- CGA资源强度从25%(个案管理方案)到81%(综合评估)不等,仅5项研究计入非正式照护者成本。
核心结论
- CGA的成本效果仍不确定,资源强度、衰弱严重程度、居住状态和场景的差异可能解释研究间的异质性。
研究设计与样本
- 系统综述检索五个数据库的全经济学评价研究,纳入≥65岁衰弱或不良结局风险成人,最终纳入17项研究,覆盖7种场景(11项社区、6项医院)。
- 由两名独立评审员按预设标准筛选和提取数据,采用CHEERS框架评估报告质量,结果以叙述性总结、表格和图形呈现。
主要发现
- 13项成本效用分析中,增量QALY范围为-0.06至0.54,增量成本范围为€-12 744至€29 785。
- CGA具有成本效果的概率在所述支付意愿阈值下为0%至98.9%,5/13项具成本效果、7/13项不具成本效果、1/13项为50%概率。
- 两项研究显示成本效果可随衰弱严重程度和居住状态变化。
- CGA的资源强度从25%(个案管理方案)到81%(综合评估)不等,仅5项研究计入非正式照护者成本。
- 报告质量范围为38%至90%。
关键数值与推荐
- 纳入标准为≥65岁、被识别为衰弱或存在不良结局风险的成人,研究类型为全经济学评价。
- 成本效果判定基于各研究报告的支付意愿阈值,概率范围为0%至98.9%。
- 报告质量采用CHEERS框架评估,得分范围38%至90%。
临床怎么用
- 解读CGA经济学证据时需注意资源强度、衰弱严重程度、居住状态和场景的差异对成本效果的影响。
- 在老年医学科决策中引用成本效果数据时,应结合本机构CGA的资源投入模式和目标人群特征。
- 评估CGA经济性时需关注是否计入非正式照护者成本,因仅少数研究纳入该成本。
局限性
- 纳入研究间CGA资源强度、衰弱严重程度、居住状态和场景存在异质性,成本效果结果不一致。
- 仅5项研究计入非正式照护者成本,报告质量范围为38%至90%,可能影响证据合成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Comprehensive geriatric assessment (CGA) can be resource-intensive as its delivery involves multidisciplinary personnel, multidimensional assessment, care planning and follow-up. The aim of this systematic review is to appraise and synthesise evidence on the cost-effectiveness of CGA across settings. METHODS: Full economic evaluation studies examining CGA were searched across five databases. We included studies involving adults aged ≥65 years who were identified as living with frailty or at risk of adverse outcomes. Two independent reviewers screened studies against eligibility criteria and extracted data using a pretested extraction form. Reporting quality was assessed using the Consolidated Health Economic Evaluation Reporting Standards framework. We reported the results through narrative summaries, tables and figures. RESULTS: A total of 4864 studies were identified, of which 17 were included across 7 settings (11 community, 6 hospital). Of 13 cost-utility analysis studies, incremental quality-adjusted life years ranged from -0.06 to 0.54 and incremental costs ranged from €-12 744 to €29 785. The probability CGA was cost-effective ranged from 0% to 98.9% across stated willingness-to-pay thresholds (cost-effective in 5/13, not cost-effective in 7/13, 50% chance in 1/13). Two studies showed that cost-effectiveness can vary by frailty severity and residential status. The resource intensity of CGA varied, ranging from 25% (case management protocol) to 81% (comprehensive assessment). Only five studies accounted for informal caregiver costs. The reporting quality ranged from 38% to 90%. CONCLUSION: The cost-effectiveness of CGA remains uncertain. Variations in resource intensity of CGA, frailty severity, residential status of older adults and setting may explain this heterogeneity. PROSPERO REGISTRATION NO: CRD42023492586.
引用
- Yigezu AL, Hayes C, Galvin R, et al. Cost-effectiveness of comprehensive geriatric assessment: systematic review of economic evaluations. Age Ageing. 2026. PMID: 42437530. doi:10.1093/ageing/afag203
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。